爾康制(zhi)藥(300267)1月5日晚公(gong)告,公(gong)司(si)(si)控股股東、實際控制(zhi)人(ren)帥(shuai)放文(wen)(wen)因(yin)為(wei)個(ge)人(ren)資金需求(qiu),將(jiang)所持(chi)1000萬股質押給華泰證券。截止公(gong)告日,帥(shuai)放文(wen)(wen)共(gong)(gong)持(chi)有公(gong)司(si)(si)股份8.55億股,占(zhan)公(gong)司(si)(si)總股本(ben)41.44%。截至(zhi)公(gong)告日,帥(shuai)放文(wen)(wen)共(gong)(gong)質押5.09億股公(gong)司(si)(si)股份,占(zhan)其持(chi)有公(gong)司(si)(si)股份59.57%,占(zhan)公(gong)司(si)(si)總股本(ben)24.68%。